146 related articles for article (PubMed ID: 12005258)
1. Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine.
Kuo DY; Hsu CT; Cheng JT
Life Sci; 2001 Dec; 70(3):243-51. PubMed ID: 12005258
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression.
Kuo DY
Behav Brain Res; 2003 Dec; 147(1-2):149-55. PubMed ID: 14659580
[TBL] [Abstract][Full Text] [Related]
3. Effect of amphetamine repeated treatment on the feeding behavior in neuropeptide Y-overexpressing mice.
Kuo DY; Inui A; Cheng JT
Neurosci Lett; 2002 Sep; 329(3):359-61. PubMed ID: 12183048
[TBL] [Abstract][Full Text] [Related]
4. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats.
Hsieh YS; Chen PN; Yu CH; Chen CH; Tsai TT; Kuo DY
Neurotoxicology; 2015 May; 48():131-41. PubMed ID: 25825358
[TBL] [Abstract][Full Text] [Related]
5. Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression.
Hsieh YS; Yang SF; Chiou HL; Kuo DY
Toxicol Appl Pharmacol; 2006 Apr; 212(2):99-109. PubMed ID: 16084549
[TBL] [Abstract][Full Text] [Related]
6. Both neuropeptide Y knockdown and Y1 receptor inhibition modulate CART-mediated appetite control.
Chu SC; Chen PN; Ho YJ; Yu CH; Hsieh YS; Kuo DY
Horm Behav; 2015 Jan; 67():38-47. PubMed ID: 25461972
[TBL] [Abstract][Full Text] [Related]
7. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.
Kuo DY
Regul Pept; 2005 Apr; 127(1-3):19-26. PubMed ID: 15680466
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.
Hsieh YS; Yang SF; Kuo DY
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E123-31. PubMed ID: 16896163
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum.
Hsieh YS; Yang SF; Kuo DY
Regul Pept; 2005 Apr; 127(1-3):169-76. PubMed ID: 15680483
[TBL] [Abstract][Full Text] [Related]
10. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
11. The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
Mol Brain; 2013 Nov; 6():46. PubMed ID: 24225225
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling.
Kuo DY; Yang SF; Chu SC; Chu SC; Chen CH; Hsieh YS
Chem Biol Interact; 2009 Jul; 180(2):193-201. PubMed ID: 19497417
[TBL] [Abstract][Full Text] [Related]
13. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
Hsieh YS; Yang SF; Chiou HL; Kuo DY
Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
[TBL] [Abstract][Full Text] [Related]
14. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats.
Hsieh YS; Yang SF; Chen PN; Chu SC; Chen CH; Kuo DY
J Psychopharmacol; 2011 Jul; 25(7):982-94. PubMed ID: 20817751
[TBL] [Abstract][Full Text] [Related]
15. Double immunofluorescent evidence that oxidative stress-associated activation of JNK/AP-1 signaling participates in neuropeptide-mediated appetite control.
Chu SC; Chen PN; Yu CH; Hsieh YS; Kuo DY
Eur Neuropsychopharmacol; 2019 Nov; 29(11):1235-1249. PubMed ID: 31519469
[TBL] [Abstract][Full Text] [Related]
16. Participation of ghrelin signalling in the reciprocal regulation of hypothalamic NPY/POMC-mediated appetite control in amphetamine-treated rats.
Yu CH; Chu SC; Chen PN; Hsieh YS; Kuo DY
Appetite; 2017 Jun; 113():30-40. PubMed ID: 28229938
[TBL] [Abstract][Full Text] [Related]
17. Role of hypothalamic leptin-LepRb signaling in NPY-CART-mediated appetite suppression in amphetamine-treated rats.
Chu SC; Chen PN; Chen JR; Yu CH; Hsieh YS; Kuo DY
Horm Behav; 2018 Feb; 98():173-182. PubMed ID: 29307696
[TBL] [Abstract][Full Text] [Related]
18. NF-κB knockdown can modulate amphetamine-mediated feeding response.
Kuo DY; Chen PN; Kuo MH; Chen CH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Mar; 62(4):1684-94. PubMed ID: 22182781
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia-inducible factor-1α in regulating oxidative stress and hypothalamic neuropeptides-mediated appetite control.
Chu SC; Chen PN; Yu CH; Hsieh YS; Kuo DY
Brain Res; 2019 Oct; 1721():146329. PubMed ID: 31295466
[TBL] [Abstract][Full Text] [Related]
20. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
